期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 144, 期 11, 页码 4739-4745出版社
AMER CHEMICAL SOC
DOI: 10.1021/jacs.2c00251
关键词
-
资金
- U.S. Army Research Office [W911NF-19-D-0001, W911NF-19-2-0026]
- Ruth Kirschstein NIH Postdoctoral Fellowship [F32GM128247]
The study reports the enantioselective one-carbon ring expansion of aziridines to form azetidines through engineered carbene transferase enzymes. A variant of cytochrome P450BM3, P411-AzetS, showed unparalleled stereocontrol (99:1 er) in the [1,2]-Stevens rearrangement and could override the inherent reactivity of aziridinium ylides to perform this rearrangement. By controlling the reactive aziridinium ylide intermediates, these evolvable biocatalysts enable a transformation not achievable by other catalyst classes.
We report enantioselective one-carbon ring expansion of aziridines to make azetidines as a new-to-nature activity ofengineeredcarbene transferaseenzymes. A laboratory-evolved variant of cytochrome P450BM3, P411-AzetS, not only exertsunparalleled stereocontrol (99:1 er) over a [1,2]-Stevens rearrangement but also overrides the inherent reactivity of aziridiniumylides, cheletropic extrusion of olefins, to perform a [1,2]-Stevens rearrangement. By controlling the fate of the highly reactiveaziridinium ylide intermediates, these evolvable biocatalysts promote a transformation which cannot currently be performed usingother catalyst classes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据